{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicsyvmg3fzvbunz3p4oszrub42pf5uzbmlhaydtaftxjpk2fpmq7q",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mleacq2jmbb2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreih73n2nnaqcje6ie7efhollrm3wddug476zz5kj32dytvlqhz53jy"
    },
    "mimeType": "image/jpeg",
    "size": 262987
  },
  "path": "/news/2026-05-common-asthma-drug-reversing-fatty.html",
  "publishedAt": "2026-05-08T13:00:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide. It is also a leading cause of liver transplantation, yet treatment options remain limited.",
  "title": "Common asthma drug shows promise for reversing fatty liver"
}